Navigation Links
The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study
Date:10/3/2008

Burlington County, New Jersey is the newest study site

PHILADELPHIA, Oct. 3 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia today received a contract to manage a new study site in The National Children's Study. Children's Hospital will manage local participation, recruitment and data collection in Burlington County, New Jersey. The study is funded by the National Institutes of Health.

Investigators anticipate approximately 1,000 families in Burlington County will participate in the study that will follow children from before birth until age 21. The National Children's Study eventually will follow a representative sample of 100,000 children from across the U.S., seeking information to prevent and treat some of the nation's most pressing health problems, including autism, birth defects, diabetes, heart disease and obesity.

"The children enrolled from Burlington County represent a snapshot of all of America's children," said Jennifer Culhane, Ph.D., M.P.H., principal investigator of The Children's Hospital of Philadelphia Study Center. "The National Children's Study provides us with a great opportunity to contribute to improving the health of children and families in this county and across the nation for generations to come."

In the new coverage area Virtua Health, Lourdes Health System and Capital Health System will participate. The study will be conducted in conjunction with the Burlington County Health Department.

"By following 100,000 children from before birth to age 21, we hope to better understand how children's genes and their environment interact to affect their health and development," Dr. Culhane added.

In November 2005, the National Children's Study named Montgomery County, Pa. one of seven Vanguard sites in the nation charged with studying children's health determinants. Schuylkill County, Pa, New Castle County, Del. and Philadelphia County were added to the list of locations managed by Ch
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire/-- ChemoCentryx,Inc.,announcedtodayt...1(theProspectiveRandomizedOralTherapyEvaluationinC...tientswithmoderate-to-severeCrohn,sdiseasedemonstr...ilityprofile.Thestudydemonstratedevidenceofclinica...sa70-pointdecreaseintheCrohn,sDiseaseActivityIndex...
(Date:11/24/2009)...swire-FirstCall/--QuestDiagnosticsIncorporated(NYS...ing,informationandservices,announcedthatitisschedu...ferenceinNewYorkCity.Thepresentationisscheduledfor..., Duringtheconference,thecompanywillreaffirmits20...gincometoexceed18%ofrevenues,anddilutedearningsper...
(Date:11/24/2009)...wire/--Inadditiontofamily,friendsandhealth,cancers...rThanksgivinggratitudelist. ,, "Theyheardthefac...dofMonday,sverdictstotaling$103millionindamagesaga...000womennationwidewhohavesuedWyethandPfizerpharmac...Prempro.Wisneskiandtheothervictimsofhormonetherapy...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Curcumin may inhibit nicotine induced activation of head and neck cancers 58834 1Patients with chronic rhinosinusitis have increased incidence of other chronic illnesses 58830 1Understanding a cells split personality aids synthetic circuits 10253 1Understanding a cells split personality aids synthetic circuits 10253 2Understanding a cells split personality aids synthetic circuits 10253 3
...ints Achieved for SCOLR,s 12-Hour ...SCOLR Pharma, Inc.,(Amex: DDD ) today reported fi...d September 30, 2008. The Company will host a live... a.m. (Eastern Standard Time)., Daniel O. Wilds, ...very,productive third quarter making significant p...
... Corporation today,announced that the company has ... Cancer Institute,s Nanotechnology Characterizatio... Versamune(TM)-HPV prior to filing of,the Investig... selected,physical, chemical and biological studie...e National Cancer Institute (NCI) in Frederick, Ma...
Other Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results 8PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 2
(Date:11/26/2009)...n Communications announces a highly effective and ...s struggling to make an economic recovery. , ...lu fears is the type of challenge that could send ...ing to Dr. David Benton, business growth expert an...tem – The Rfactor Intensive . “Fear...
(Date:11/25/2009)...RNewswire/--TheBartleHallConventionCenterwilltempo...-10,whenKansasCityhoststhelatestinaseriesofmassive...iceventhasthepotentialtobethebiggestoneyet,because...weekdaysinsteadofoveraweekend,"SheriWood,executive...toftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009)...swire-USNewswire/--TheBlackAIDSInstituterecentlyhe...ershipfor2010. ,, ThenewBoardMembersareahighlyd...law,finance,governmenthealthprograms,editorial,and...erangeofpersonalbackgroundsincludingbothheterosexu...es,andrepresentingmultipleagegroups. ,, (Photo:...
(Date:11/25/2009)...ular cancer who were treated with cisplatin-based ...ng neurological side effects and Raynaud-like phen...rapy, according to a new study published online No...nstitute . , Marianne Brydy, M.D., of the Depart...n Bergen, Norway, and colleagues conducted a cross...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...c.,(Pink Sheets: MEDQ.PK) today announced that it ...Q for the first two quarters of 2007 and expects,f...e Commission (SEC) by,the middle of October 2007. ... time since the filing of its Form,10-Q for the th...
... lives of patients who have suffered a stroke and ...o a study published on bmj.com today. , Stroke ...and the leading cause of serious, long-term disabi...g, dressing and going to the toilet. We already k...
...as the elderly and people with physical or mental ...n assisted death are not supported by evidence, sa...ted death (both voluntary active euthanasia and ph...uicide was also legalised in Oregon in 1997, write...
... for a $100 million initiative to create an instit...lth problems in the developing world, such as HIV/...nced today during the annual meeting of the Clinto..., with the goal of establishing an institute that ...
...completion, SAN FRANCISCO, Sept. 28 Inspired fat...five-month 2,200-mile fundraising journey to,the G...n San Francisco,Calif., two weeks ahead of schedul...y 19 years. Among centers serving the development...
...on,Pharmaceuticals LLC, a clinical-stage drug deve...gs utilizing a novel mechanism of action,that enha... of a Phase I,safety trial of its lead drug candid... support the company,s overall growth,and advance ...
Other Medicine News:Health News:MedQuist Updates Status of Outstanding SEC Filings 2Health News:Vulnerable groups are not at higher risk of physician-assisted death 2Health News:Rice unveils $100 million initiative for world health technology 2Health News:Rice unveils $100 million initiative for world health technology 3Health News:Man Walking to California for Son Approaching Finish Line 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 3Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 4
...gitators offer a wide range of storage capacities....e platform to agitate smoothly, eliminating the ne...turdy, one-piece perforated drawers with non-slip ...or your platelets., ,i.Series platelet agitato...
Platelet Agitator 4721
SR48336 Reciprocating Shaker
Reciprocating Platelet Shaker TPS-32
Medicine Products: